CANADA LIFE ASSURANCE Co
InsurancePosition in PTGX — Protagonist Therapeutics, Inc
CIK 1046192
WINNIPEG, A2
Position in PTGX
as of Jun 30, 2026
· filed Aug 13, 2026
Position Value
$5,889,356
+$889,180 QoQ
Shares Held
48,045
+1.3% QoQ
Ownership
0.074%
of shares outstanding
% of Portfolio
0.01%
of 13F equity value
Holder Rank
#96
of 341 holders
Holding Since
Dec 2020
23 quarters on record
Voting authority
Sole 100%
Shared 0%
None 0%
Common Shares in PTGX Over Time
Shares Held
Position Value (USD)
Position in Biotechnology
Healthcare · as of Jun 30, 2026CANADA LIFE ASSURANCE Co holds $333,087,992 across 79 Biotechnology names. PTGX ranks #16 (1.8% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | VRTX |
Vertex Pharmaceuticals Inc / Ma
|
182,365 | $90,586,166 | |
| 2 | REGN |
Regeneron Pharmaceuticals, Inc.
|
86,761 | $54,098,953 | |
| 3 | ALNY |
Alnylam Pharmaceuticals, Inc.
|
69,102 | $20,801,775 | |
| 4 | INCY |
Incyte Corp
|
126,229 | $14,309,319 | |
| 5 | ARGX |
Argenx SE
|
14,868 | $13,794,084 | |
| 6 | MRNA |
Moderna, Inc.
|
152,228 | $10,660,526 | |
| 7 | RPRX |
Royalty Pharma plc
|
185,316 | $10,390,668 | |
| 8 | EXEL |
Exelixis, Inc.
|
155,922 | $8,483,716 |
All Filings in PTGX
Export CSV
23 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-06-30 | $5,889,356 | 48,045 | Shares | Sole | 2026-08-13 | |
| 2026-03-31 | $5,000,176 | 47,440 | Shares | Sole | 2026-05-14 | |
| 2025-12-31 | $4,335,557 | 49,640 | Shares | Sole | 2026-02-13 | |
| 2025-09-30 | $3,215,677 | 48,407 | Shares | Sole | 2025-11-17 | |
| 2025-06-30 | $2,776,875 | 50,242 | Shares | Sole | 2025-08-15 | |
| 2025-03-31 | $2,464,183 | 50,955 | Shares | Sole | 2025-05-15 | |
| 2024-12-31 | $2,182,289 | 56,536 | Shares | Sole | 2025-02-13 | |
| 2024-09-30 | $2,544,120 | 56,536 | Shares | Sole | 2024-11-13 | |
| 2024-06-30 | $180,630 | 5,213 | Shares | Sole | 2024-08-12 | |
| 2024-03-31 | $262,771 | 9,083 | Shares | Sole | 2024-05-13 | |
| 2023-12-31 | $119,534 | 5,213 | Shares | Sole | 2024-02-13 | |
| 2023-09-30 | $86,952 | 5,213 | Shares | Sole | 2023-11-14 | |
| 2023-06-30 | $54,742 | 1,982 | Shares | Sole | 2023-08-10 | |
| 2023-03-31 | $45,586 | 1,982 | Shares | Sole | 2023-05-12 | |
| 2022-12-31 | $21,623 | 1,982 | Shares | Sole | 2023-02-10 | |
| 2022-09-30 | $16,708 | 1,982 | Shares | Sole | 2022-11-01 | |
| 2022-06-30 | $15,677 | 1,982 | Shares | Sole | 2022-08-09 | |
| 2022-03-31 | $46,933 | 1,982 | Shares | Sole | 2022-05-12 | |
| 2021-12-31 | $67,784 | 1,982 | Shares | Defined | 2022-02-14 | |
| 2021-09-30 | $35,121 | 1,982 | Shares | Defined | 2021-11-15 | |
| 2021-06-30 | $88,952 | 1,982 | Shares | Defined | 2021-08-11 | |
| 2021-03-31 | $51,333 | 1,982 | Shares | Defined | 2021-05-17 | |
| 2020-12-31 | $39,957 | 1,982 | Shares | Defined | 2021-02-16 | |
| No filing history on record for this holder in this stock. | ||||||